Downloads

  1. Your Partner For Chemocatalysis Solutions 6/20/2025

    Chemocatalyzed steps in synthetic routes are known to afford high selectivities, yields and atom economy. A chemocatalytic reaction optimization requires large number of experiments to identify a suitable catalyst, catalyst loading, solvent, temperature, pressure etc. The chemocatalysis team at Aragen Life Sciences has the capabilities to optimize processes using high throughput screening combined with DoE from gram to multikilo scale with ready access to catalysts and ligands.

  2. Ask The Pros — The Latest In Downstream HCP Mitigation 6/20/2025

    Two downstream biologics processing experts address some of the field's complex, nagging questions about mitigating host cell proteins.

  3. Organoid-Based Drug Screening Services 6/20/2025

    With a focus on scientific rigor and adaptability, our organoid solutions empower researchers to optimize candidate selection and accelerate development timelines.

  4. How Is RIM Software Transforming Regulatory Compliance? 6/20/2025

    Regulatory information management (RIM) software tools streamline global regulatory processes on a single cloud-based platform throughout the entire product life cycle.

  5. Discover In Vitro Glycoengineering 6/19/2025

    Variations in glycosylation can impact your therapeutic protein's safety and efficacy. Take control of this critical quality attribute with in vitro glycoengineering for predictable outcomes.

  6. Best Practices For Scaling PSC Expansion From Bench To Pilot To Commercial Scale 6/19/2025

    Achieve reproducible and robust PSC expansion with proven best practices. This session covers single-cell passaging, perfusion feeding, and in-vessel harvesting to streamline your process for efficient, linear scale-up.

  7. Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development 6/19/2025

    Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

  8. Draft EMA Doc Proposes More Flexibility On Biosimilar CES Requirements 6/19/2025

    Clinical efficacy studies may not be necessary under certain conditions, writes the European Medicines Agency in a new draft reflection paper.

  9. Uncovering Blind Spots In Environmental Monitoring 6/19/2025

    Discover how modern strategies like the Contamination Control Strategy are transforming environmental monitoring by exposing hidden risks, enhancing data quality, and unlocking deeper insights through innovative microbial methods.

  10. Guide To Seeding, Expanding, And Harvesting Stem Cells 6/18/2025

    Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.